Baxter International INC Form 4 insider transactions

David S. Rosenbloom, EVP and General Counsel of Baxter International, reports the forfeiture of 784 shares to cover tax withholding related to vested restricted stock units.

Director Peter M. Wilver reports acquisition of shares through a grant and dividend reinvestment, and disposal of shares.

Director David S. Wilkes reports acquiring 5,952 shares of Baxter International Inc. common stock on May 7, 2024.

Director Amy McBride Wendell reports receiving a grant of Baxter International Inc. common stock and discloses total holdings.

Director Cathy R. Smith reports acquiring 5,952 shares of Baxter International Inc. common stock on May 7, 2024, through a grant of fully vested shares.

Director David Brent Shafer reports the acquisition of 5,952 shares of Baxter International Inc. common stock on May 7, 2024.

Director Nancy M. Schlichting reports the acquisition of 5,952 shares of Baxter International common stock on May 7, 2024.

Director Stephen Rusckowski reports acquiring 5,952 shares of Baxter International common stock on May 7, 2024.

Director Stephen N. Oesterle reports acquiring 5,952 shares of Baxter International Inc. common stock on May 7, 2024, through a grant and dividend reinvestment.

Director Patricia Morrison acquired 5,952 shares of Baxter International common stock on May 7, 2024, as reported in a Form 4 filing with the SEC.

Director William A. Ampofo II reports acquiring 5,952 shares of Baxter International common stock on May 7, 2024.

Christopher A. Toth, EVP of Baxter International, reports the acquisition of restricted stock units (RSUs) as part of his annual equity grant.

Brian Stevens, SVP, CAO & Controller of Baxter International Inc., reports the acquisition of restricted stock units (RSUs) as part of his annual equity grant.

Alok Sonig, EVP and Group President, Pharma at Baxter International, reported the acquisition of restricted stock units (RSUs) and a resulting adjustment in their beneficial ownership of company stock on March 6, 2024.

David S. Rosenbloom, EVP and General Counsel of Baxter International, reports the acquisition of 53,584 shares and disposal of 108,989 shares of common stock on March 6, 2024, following the grant of restricted stock units.

Reazur Rasul, EVP at Baxter International, reports the acquisition of 83,353 shares of common stock and disposal of 109,187 shares.

Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, reports the acquisition of restricted stock units (RSUs) as part of her annual equity grant.

James W. Borzi, EVP and Chief Supply Chain Officer at Baxter International, reported the acquisition of restricted stock units (RSUs) as part of his annual equity grant.

Heather Knight, EVP, Group President, Medical Products at Baxter International, reported the acquisition of restricted stock units (RSUs) as part of her annual equity grant.

Baxter International's CEO, Jose Almeida, received an annual equity grant consisting of restricted stock units (RSUs) that vest in three equal annual installments starting March 6, 2025.

Joel T. Grade, EVP and CFO of Baxter International, reports the acquisition of 42,867 shares of common stock and holdings of 96,623 shares.

Brian Stevens, SVP, CAO & Controller of Baxter International, reports the forfeiture of 545 common stock shares to cover tax withholding related to the settlement of vested restricted stock units.

Reazur Rasul, EVP at Baxter International, reports the forfeiture of 522 shares to cover tax withholding related to vested restricted stock units.

Heather Knight, EVP, Group President, Med Products at Baxter International, reports a transaction involving the forfeiture of shares to cover tax withholdings related to the vesting of restricted stock units.

Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, reports a transaction involving the forfeiture of 475 shares to cover tax withholding related to vested restricted stock units.

EVP, Chief Supply Chain Officer of Baxter International, James W. Borzi, reports the forfeiture of 420 shares to cover tax withholding related to vested restricted stock units.

Jose Almeida, CEO of Baxter International, reported the forfeiture of 4,779 shares to cover tax withholding obligations related to the vesting of restricted stock units.

Brian Stevens, SVP, CAO & Controller of Baxter International, reports the forfeiture of 673 common stock shares to cover tax withholding related to the vesting of restricted stock units on March 1, 2024.

Alok Sonig, EVP at Baxter International, reports a transaction involving common stock to cover tax withholding related to vested restricted stock units.

David S. Rosenbloom, EVP and General Counsel of Baxter International, reports the forfeiture of 1,416 shares to cover tax withholding related to vested restricted stock units.